Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats

Experimental Physiology

Volumn 92, Issue 1, 2007, Pages 147-159

  Itoh, Tetsuji ^a   Haruna, Masao ^a   Abe, Kohji ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME INHIBITION; GENE CONTROL; HEART; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERTENSION; MALE; NONHUMAN; RAT; STROKE; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 33846249936     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.035097     Document Type: Article

References (44)

1. Abe K, Tokumura M, Itoh T, Murai T, Takashima A & Ibii N (2001). Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 280, H668-H673.
2. Beckman JS & Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, C1424-C1437.
3. Carlos DM, Goto S, Urata Y, Iida T, Cho S, Niwa M, Tsuji Y & Kondo T (1998). Nicardipine normalizes elevated levels of antioxidant activity in response to xanthine oxidase-induced oxidative stress in hypertensive rat heart. Free Radic Res 29, 143-150.
4. Chen H, Higashino H, Maeda K, Zhang Z, Ohta Y, Wang Z, Su DF & Yuan WJ (2001). Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 38, 821-832.
5. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T & Luscher TF (1998). Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 101, 1530-1537.
6. Crabos M, Coste P, Paccalin M, Tariosse L, Daret D, Besse P & Bonoron-Adele S (1997). Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 29, 55-65.
7. Draper NJ & Shah AM (1997). Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart. J Mol Cell Cardiol 29, 1195-1205.
8. Du Toit EF, McCarthy J, Miyashiro J, Opie LH & Brunner F (1998). Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. Br J Pharmacol 123, 1159-1167.
9. Du Toit EF, Meiring J & Opie LH (2001). Relation of cyclic nucleotide ratios to ischemic and reperfusion injury in nitric oxide-donor treated rat hearts. J Cardiovasc Pharmacol 38, 529-538.
10. Ecker T, Gobel C, Hullin R, Rettig R, Seitz G & Hofmann F (1989). Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res 65, 1361-1369.
11. Engelman DT, Watanabe M, Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW & Das DK (1996). Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion. Circulation 94 (Suppl. 9), II407-II411.
12. Feil R, Lohmann SM, De Jonge H, Walter U & Hofmann F (2003). Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 93, 907-916.
13. Ferdinandy P & Schulz R (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138, 532-543.
14. Gerzanich V, Ivanov A, Ivanova S, Yang JB, Zhou H, Dong Y & Simard JM (2003). Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle. Circ Res 93, 805-812.
15. Giraldez RR, Panda A, Xia Y, Sanders SP & Zweier JL (1997). Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J Biol Chem 272, 21420-21426.
16. Gorren AC, Schrammel A, Schmidt K & Mayer B (1998). Effects of pH on the structure and function of neuronal nitric oxide synthase. Biochem J 331, 801-807.
17. Hanafy KA, Krumenacker JS & Murad F (2001). NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 7, 801-819.
18. Hare JM & Stamler JS (2005). NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115, 509-517.
19. Ito N, Bartunek J, Spitzer KW & Lorell BH (1997). Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95, 2303-2311.
20. Itoh T, Abe K, Tokumura M, Hirono S, Haruna M & Ibii N (2004). Cardiac mechanical dysfunction induced by ischemia-reperfusion in perfused heart isolated from stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 26, 485-498.
21. Keilbach A, Ruth P & Hofmann F (1992). Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208, 467-473.
22. Kelly R, Balligand JL & Smith TW (1996). Nitric oxide and cardiac function. Circ Res 79, 363-380.
23. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM & Casadei B (2005). A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97, 629-636.
24. Kitakaze M, Node K, Takashima S, Asanuma H, Asakura M, Sanada S, Shinozaki Y, Mori H, Sato H, Kuzuya T & Hori M (2001). Role of cellular acidosis in production of nitric oxide in canine ischemic myocardium. J Mol Cell Cardiol 33, 1727-1737.
25. Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J & Nakagawa M (2003). The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 98, 319-328.
26. Kojda G, Kottenberg K, Hacker A & Noack E (1998). Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats. Pharm Acta Helv 73, 27-35.
27. Labarthe F, Khairallah M, Bouchard B, Stanley WC & Des Rosiers C (2005). Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am J Physiol Heart Circ Physiol 288, H1425-H1436.
28. Levy D, Garrison RJ, Savage DD, Kannel WB & Castelli WP (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322, 1561-1566.
29. MacCarthy PA & Shah AM (2000). The role of nitric oxide in cardiac ischemia-reperfusion. In Handbook of Experimental Pharmacology, vol. 143, Nitric Oxide, ed. Mayer B, pp. 545-570. Springer-Verlag, Berlin.
30. Mazzetti L, Ruocco C, Giovannelli L, Ciuffi M, Franchi-Micheli S, Marra F, Zilletti L & Failli P (2001). Guanosine 3′: 5′-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats. Br J Pharmacol 134, 596-602.
31. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A 88, 1197-1201.
32. Muscari C, Bonafe F, Gamberini C, Giordano E, Tantini B, Fattori M, Guarnieri C & Caldarera CM (2004). Early preconditioning prevents the loss of endothelial nitric oxide synthase and enhances its activity in the ischemic/reperfused rat heart. Life Sci 74, 1127-1137.
33. Pabla R & Curtis MJ (1996). Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart. J Mol Cell Cardiol 28, 2097-2110.
34. Piech A, Dessy C, Havaux X, Feron O & Balligand JL (2003). Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 57, 456-467.
35. Schoemaker RG, Leenen FH & Harmsen E (1994). Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril. J Mol Cell Cardiol 26, 649-660.
36. Shah AM (1996). Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 31, 847-867.
37. Shah AM & MacCarthy PA (2000). Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86, 49-86.
38. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B, Lazzarino G, Paolocci N, Gabrielson KL, Wang Y & Kass DA (2005). Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115, 1221-1231.
39. Vasquez-Vivar J, Kalyanaraman B & Martasek P (2003). The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 37, 121-127.
40. Wang P & Zweier JL (1996). Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271, 29223-29230.
41. 2+-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol 29, 291-296.
42. Williams MW, Taft CS, Ramnauth S, Zhao ZQ & Vinten-Johansen J (1995). Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 30, 79-86.
43. Xie YW, Kaminski PM & Wolin MS (1998). Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 82, 891-897.
44. Yasmin W, Strynadka KD & Schulz R (1997). Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33, 422-432.